Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study

Jan Endrikat; Susanne Parke; Dietmar Trummer; Marco Serrani; Ingrid Duijkers; Christine Klipping

doi:10.1016/j.contraception.2012.07.008

Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study

Contraception ◽

10.1016/j.contraception.2012.07.008 ◽

2013 ◽

Vol 87 (2) ◽

pp. 227-234 ◽

Cited By ~ 11

Author(s):

Jan Endrikat ◽

Susanne Parke ◽

Dietmar Trummer ◽

Marco Serrani ◽

Ingrid Duijkers ◽

...

Keyword(s):

Oral Contraceptive ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Combined Oral Contraceptive

Download Full-text

Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women

The European Journal of Contraception & Reproductive Health Care ◽

10.3109/13625187.2014.918596 ◽

2014 ◽

Vol 19 (4) ◽

pp. 285-294 ◽

Cited By ~ 5

Author(s):

Rossella E. Nappi ◽

Anna Maria Paoletti ◽

Annibale Volpe ◽

Luca Chiovato ◽

Brandon Howard ◽

...

Keyword(s):

Oral Contraceptive ◽

Oral Contraceptives ◽

Open Label ◽

Open Label Study ◽

Combined Oral Contraceptives ◽

Label Study ◽

Combined Oral Contraceptive ◽

Healthy Women ◽

The Impact

Download Full-text

Lack of a Pharmacokinetic Interaction Between SYM-1219 Granules Containing 2 Grams of Secnidazole and a Combined Oral Contraceptive in a Phase 1, Randomized, Open-Label Study in Healthy Female Volunteers

Advances in Therapy ◽

10.1007/s12325-016-0411-9 ◽

2016 ◽

Vol 33 (12) ◽

pp. 2229-2241 ◽

Cited By ~ 7

Author(s):

Helen S. Pentikis ◽

Nikki Adetoro ◽

Carol J. Braun

Keyword(s):

Oral Contraceptive ◽

Phase 1 ◽

Pharmacokinetic Interaction ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Combined Oral Contraceptive ◽

Healthy Female

Download Full-text

A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation

The European Journal of Contraception & Reproductive Health Care ◽

10.3109/13625187.2014.979282 ◽

2014 ◽

Vol 20 (4) ◽

pp. 249-258 ◽

Cited By ~ 6

Author(s):

Robin Kroll ◽

Larry Seidman ◽

Nancy Ricciotti ◽

Brandon Howard ◽

Herman Weiss

Keyword(s):

Oral Contraceptive ◽

Low Dose ◽

Ethinyl Estradiol ◽

Phase 1 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Hormone Levels ◽

Combined Oral Contraceptive ◽

Follicular Activity

Download Full-text

Multicenter open-label study to evaluate efficacy and safety of an ascending-dose, extended-regimen ethinyl estradiol/levonorgestrel combination oral contraceptive for preventing pregnancy in women

Fertility and Sterility ◽

10.1016/j.fertnstert.2012.07.718 ◽

2012 ◽

Vol 98 (3) ◽

pp. S196-S197 ◽

Cited By ~ 1

Author(s):

D.J. Portman ◽

B. Howard ◽

H. Weiss ◽

A.M. Kaunitz ◽

N. Ricciotti

Keyword(s):

Oral Contraceptive ◽

Ethinyl Estradiol ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

A prospective open-label study to evaluate the effects of the oral contraceptive Harmonet® (gestodene75/EE20) on body fat

Contraception ◽

10.1016/j.contraception.2003.10.016 ◽

2004 ◽

Vol 70 (1) ◽

pp. 65-71 ◽

Cited By ~ 19

Author(s):

N.R de Melo ◽

J.M Aldrighi ◽

D Faggion ◽

V.R.O.Y Reyes ◽

J.B Souza ◽

...

Keyword(s):

Oral Contraceptive ◽

Body Fat ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

Hemostatic effects of two oral contraceptive regimens: a multinational, multicenter, randomized, open-label study

Fertility and Sterility ◽

10.1016/j.fertnstert.2013.07.962 ◽

2013 ◽

Vol 100 (3) ◽

pp. S313

Author(s):

N. Ricciotti ◽

B. Howard ◽

H. Weiss

Keyword(s):

Oral Contraceptive ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Hemostatic Effects

Download Full-text

A phase 1, open‐label study to evaluate the drug interaction between islatravir (MK‐8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females

Journal of the International AIDS Society ◽

10.1002/jia2.25858 ◽

2021 ◽

Vol 24 (12) ◽

Author(s):

Wendy Ankrom ◽

Deanne Jackson Rudd ◽

Saijuan Zhang ◽

Kerry L. Fillgrove ◽

Kezia N. Gravesande ◽

...

Keyword(s):

Drug Interaction ◽

Oral Contraceptive ◽

Healthy Adult ◽

Ethinyl Estradiol ◽

Phase 1 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Adult Females

Download Full-text

Azathloprise in refractory sprue. Results from a prospective open-label study

Gastroenterology ◽

10.1016/s0016-5085(01)81948-x ◽

2001 ◽

Vol 120 (5) ◽

pp. A392-A392 ◽

Cited By ~ 1

Author(s):

S NIVELONI ◽

A CHERNAVSKY ◽

S PEDREIRA ◽

R MAZURE ◽

H VAZQUEZ ◽

...

Keyword(s):

Open Label ◽

Open Label Study ◽

Label Study ◽

Refractory Sprue

Download Full-text

Normalization of urinary cortisol with the potent 11[beta]-hydroxylase inhibitor LCI699 in patients with Cushing's disease: 22-week, multicentre, open-label study

Endocrine Abstracts ◽

10.1530/endoabs.35.oc8.4 ◽

2014 ◽

Author(s):

Beverly Biller ◽

Jacques Young ◽

Amir Hamrahian ◽

Maria Fleseriu ◽

Mark Molitch ◽

...

Keyword(s):

Cushing’S Disease ◽

Cushing's Disease ◽

Urinary Cortisol ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

Biochemical control was sustained with long-acting pasireotide in patients with uncontrolled acromegaly over continued treatment with first-generation somatostatin analogues (SSAs): Results from the extension of phase 3b, open-label study

Endocrine Abstracts ◽

10.1530/endoabs.63.gp57 ◽

2019 ◽

Author(s):

Monica Gadelha ◽

Annamaria Colao ◽

Marie Bex ◽

Rishav Mukherjee ◽

Catherine Bourad ◽

...

Keyword(s):

First Generation ◽

Somatostatin Analogues ◽

Biochemical Control ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Long Acting

Download Full-text